期刊文献+

乳腺癌中端粒酶及凋亡相关蛋白的表达 被引量:4

Expression of telomerase gene and apoptosis related protein in breast carcinoma
全文增补中
导出
摘要 目的探讨乳腺癌组织中端粒酶反转录酶(hTERT)及凋亡相关蛋白p53、bcl-2的表达与乳腺癌可能的发生机制间的关系。方法应用免疫组织化学SP法对48例乳腺癌及配对癌旁组织、42例乳腺良性病变组织中hTERT、p53、bcl-2蛋白的表达进行检测。结果48例乳腺癌hTERT、p53、bcl-2的表达率分别为87.50%、56.25%、54.17%,与癌旁组织及乳腺良性疾病组相比,阳性表达率差异有统计学意义(P<0.05);hTERT阳性组p53、bcl-2的表达率分别为64.28%、61.90%,与阴性组相比差异有统计学意义(P<0.05)。结论端粒酶激活在乳腺癌发生过程中起重要作用,而p53基因突变及凋亡抑制基因bcl-2表达的下调在乳腺癌发生中起协同作用。 Objective To analyze the expression of telomerase and apoptosis related protein,and ex- plore the possible mechanism of breast cancer development.Methods Immunohistochemistry method(SP)was used to detect the expression of hTERT,p53 and bcl-2 in the tissues of 48 cases of human breast cancer and 42 cases of benign lesion in breast.Results The positive rates of expression of hTERT,p53 and bcl-2 in breast cancer were 87.50%,56.25%,54.17%,respectively;Compared with the groups of adjacent non- cancerous and benign lesions,there was a significant difference in three types of tissue(P<0.05);The positive rates of expression of p53 and bcl-2 in the group with positive expression of hTERT were 57.14% and 52.38%,respectively,and their difference was significant compared with the negative group(P<0.05).Con- clusion There are correlation between the activation of telomerase and p53 gene mutation in the develop- ment of breast cancer,and they are perhaps related to the down-regulation of bcl-2.
出处 《肿瘤研究与临床》 CAS 2007年第5期302-304,共3页 Cancer Research and Clinic
基金 河南省医学高新技术发展扶持项目(20060038)
关键词 乳腺肿瘤 端粒 末端转移酶 细胞凋亡 Breast neoplasms Telomerase Apoptosis
  • 相关文献

参考文献17

二级参考文献47

  • 1Ramakrishnan S, Eppenberger U,Mueller H,et al. Expression profile of the putative catalytic subunit of the telimerase gene[J]. Cancer Res, 1998,58:622-625.
  • 2Ito H, Kyo S, Kanaya T,et al. Expression of human telomerase subunit and correlation with telomerase activity in urothelial cancer [J ]. Clin Cancer Res,1998,4(3) : 1603-1608.
  • 3Suzuki T, Suziki Y, Fujioka T. Expression of the catalytic subunit assoicated with telomerase gene in human urinary bladder cancer [J]. J Urol, 1999, 162:2217-2220.
  • 4Kawakami Y,Kitamoto J. Immuno-hisochemical detection of human telomerase reverse transcriptase in human liver tissue[J]. Oncogene, 2000,19 (34) : 3888.
  • 5Kaur H,Richardson E,Murty L. Preparation of monclonal antibodies against human telomerase [ J ]. Hybridoma,2000,20(3) :183.
  • 6Fitzgerald J M, Ramchurren N, Rieger K,et al. Identification of H-ras mutation in urine sediments complements cytology in the detection of bladder tumors[J]. J Nat Cancer Inst,1995,87(2) :129-133.
  • 7Kavaler E, Landman J, Chang Y, et al.Detecting human bladder carcinoma cell in voided urine samples by assaying for the presence of telomerase activity[J].Cancer, 1998,82:708- 714.
  • 8Clin Y, Miyamoto H, Fujinami K. Telimerase activity in human bladder cancer[J]. Clin Cancer Res, 1996,2 : 929 -932.
  • 9Kamata S,Kageyama Y ,Youese J ,et al.Significant telomerase reduction in human superficial transitional cell carcinoma[J]. Br J Urol, 1996, 78 (3) : 704 -708.
  • 10Wu X X,Kakehi Y,Takahashi T,et al.Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence[J].Int J Urol,2000,7:210-217.

共引文献30

同被引文献49

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部